David Vetrie

5PUBLICATIONS
28CO-AUTHORS
Innate immunityHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 21, 2024
Activating p53 abolishes self-renewal of quiescent leukaemic stem cells in residual CML disease.

Mary T Scott, Wei Liu, Rebecca Mitchell

|Sep 29, 2021
ULK1 inhibition promotes oxidative stress-induced differentiation and sensitizes leukemic stem cells to targeted therapy.

Angela Ianniciello, Martha M Zarou, Kevin M Rattigan

|Jan 08, 2020
The leukaemia stem cell: similarities, differences and clinical prospects in CML and AML.

David Vetrie, G Vignir Helgason, Mhairi Copland

Pageof 1